SEC Form 4 · accession 0001209191-18-017581
ACORDA THERAPEUTICS INC · ACOR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ron Cohen
Officer — President and CEO · Director
Period of report
Mar 5, 2018
Accepted (ET)
Mar 7, 2018 · 7:53 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001008848
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 5, 2018 | M | 62,500 | $19.81 | A | 588,875 | D | |
| Common Stock | Mar 5, 2018 | F | 24,590 | $25.95 | D | 564,285 | D | |
| Common StockF2 | holding | — | — | — | 42,940 | I | Beneficial Ownership in Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1,F3 | $19.81 | Mar 5, 2018 | M | 62,500 | D | — | Mar 5, 2018 | Common Stock | 62,500 | 0 | D |
Explanation of responses
- F1The exercised options were scheduled to expire in 2018 on the expiration date reported within Table II unless exercised.
- F2These shares are held in a grantor retained annuity trust, which was established by the reporting person and of which he is the sole trustee.
- F3The shares subject to these options vested in installments and were fully vested on 01/01/2012.